» Articles » PMID: 28693025

Infusion of Valproic Acid Into the Renal Medulla Activates Stem Cell Population and Attenuates Salt-Sensitive Hypertension in Dahl S Rats

Overview
Date 2017 Jul 11
PMID 28693025
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Our previous study has detected a stem cell deficiency in the renal medulla in Dahl salt-sensitive (S) rats. This study determined whether infusion of valproic acid (VA), an agent known to stimulate the stem cell function, attenuated salt-sensitive hypertension in Dahl S rats.

Methods: Uninephrectomized Dahl S rats were infused with vehicle or VA (50mg/kg/d) into the renal medulla and fed with a low (LS) or high salt diet (HS). Stem cell marker and number were analyzed by immunohistochemistry, Real-time RT-PCR and Western blot. Sodium excretion and blood pressure were measured.

Results: VA significantly increased the mRNA and protein levels of FGF2, a stem cell niche factor, and CD133, a stem cell marker. The number of CD133+ cells was significantly increased in the renal medulla in VA-treated rats. Meanwhile, high salt-induced increases in the mRNA level of proinflammatory factors interleukin-1β and interleukin-6 were blocked in VA-treated rats. Functionally, sodium excretion in response to the blood pressure increase and acute sodium loading was significantly enhanced, sodium retention attenuated, high salt-induced increase of blood pressure reduced in VA-treated rats.

Conclusion: Activation of stem cell function by VA inhibits the activation of proinflammatory factors and attenuates salt-sensitive hypertension in Dahl S rats.

Citing Articles

Pathophysiology and genetics of salt-sensitive hypertension.

Maaliki D, Itani M, Itani H Front Physiol. 2022; 13:1001434.

PMID: 36176775 PMC: 9513236. DOI: 10.3389/fphys.2022.1001434.


Accumulated autophagosomes and excessive apoptosis during the luteal development of pregnant rats.

Tang Z, Huang Y, Zhang Z, Tang Y, Chen J, Sun F Int J Clin Exp Pathol. 2020; 10(12):11384-11392.

PMID: 31966494 PMC: 6966024.

References
1.
Fleig S, Humphreys B . Rationale of mesenchymal stem cell therapy in kidney injury. Nephron Clin Pract. 2014; 127(1-4):75-80. DOI: 10.1159/000363680. View

2.
Oliveira-Sales E, Maquigussa E, Semedo P, Pereira L, Ferreira V, Camara N . Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture. PLoS One. 2013; 8(11):e78464. PMC: 3817204. DOI: 10.1371/journal.pone.0078464. View

3.
Oliver J, Maarouf O, Cheema F, Martens T, Al-Awqati Q . The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004; 114(6):795-804. PMC: 516259. DOI: 10.1172/JCI20921. View

4.
Lin F, Igarashi P . Searching for stem/progenitor cells in the adult mouse kidney. J Am Soc Nephrol. 2003; 14(12):3290-2. DOI: 10.1097/01.asn.0000098682.51956.06. View

5.
Souidi N, Stolk M, Seifert M . Ischemia-reperfusion injury: beneficial effects of mesenchymal stromal cells. Curr Opin Organ Transplant. 2012; 18(1):34-43. DOI: 10.1097/MOT.0b013e32835c2a05. View